Itaúsa - Investimentos Itaú SA (ITSA3)
B3 Stock Exchange · Brazil · prices in BRL · close of 27 Oct 2026
Key indicators
| Last close | BRL 13.85 |
|---|---|
| 52-week range | 11.27 – 16.60 |
| Return, 1 month / 3 months | −2.5% / +1.0% |
| Return, 1 year / 3 years | +37.1% / +138.6% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 37 |
| Volatility (1 year) | 30.1% |
| Worst drawdown (1 year) | -15.3% |
| Average daily value traded | 2.74M BRL |
| Dividend yield | 8.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Itaúsa is a Brazilian holding company based in São Paulo that manages a portfolio of investments across several industries. Its main holding is a substantial stake in Itaú Unibanco, a private bank serving individuals and companies in Brazil and abroad. Through its other investments, Itaúsa also has interests in wood panels and building materials, chemicals, and other industrial and consumer businesses, giving it a diversified base of operations in Brazil and beyond.
Itaúsa - Investimentos Itaú SA trades under the code ITSA3 on the B3 Stock Exchange in Brazil, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Itaúsa - Investimentos Itaú SA (ITSA3) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 13.85 on 27 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 222 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 37.1% and over the last three months it rose 1.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 55 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.6% | ||
| From 52-week high | -15.3% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.0% | ||
| 6-month return | 0.6% | ||
| 12-month return, skipping the last month | 40.5% | ||
| Stability (higher is calmer) | 79 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 30.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.3% | ||
| Liquidity | 81 · Strong | Trades actively. | |
| Average daily value traded | 2.74M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 72 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 8.5% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −12.5% |
|---|---|
| 1 month | −2.5% |
| 3 months | +1.0% |
| 6 months | +0.6% |
| 1 year | +37.1% |
| 3 years | +138.6% |
| 5 years | +170.7% |
Signals
| 50-day / 200-day average | 14.41 / 13.63 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.58 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Nov 2026 | BRL 0.0242 |
| 31 Aug 2026 | BRL 0.0242 |
| 18 Jun 2026 | BRL 0.1380 |
| 29 May 2026 | BRL 0.0242 |
| 19 Mar 2026 | BRL 0.1160 |
| 27 Feb 2026 | BRL 0.0242 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.